Craif
Provider of exosome-based liquid biopsy tests intended to provide accurate and painless early cancer detection. The company's bio-platform encapsulates ribonucleic acid and relates to physiological co...
Valuation
$0
Share Price
N/A
Total Raised
$42.5M
Last Round
N/A